sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Molecular Basis of Allergic and Immunologic Disease

$694,555

Hans C. Oettgen · Boston Children'S Hospital · T32 · FY2024 · AI

Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy

$694,551

Lisa A. Cavacini · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AI

An Integrated Host-Microbe Gene Classifier to Predict SARS-CoV-2 and Severe Disease in Children with Respiratory Viral Coinfections

$694,403

Joshua Kennedy · Arkansas Children'S Hospital Res Inst · R01 · FY2024 · HL

Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy

$694,299

Yang Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI

Investigating the role of maternal-fetal crosstalk on neonatal immunity in COVID-19 infection or vaccination in pregnancy

$693,928

Stephanie Lina Gaw · University Of California, San Francisco · R01 · FY2025 · HD

Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery

$693,256

James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR

A multidimensional Digital Approach to Address Vaccine Hesitancy and Increase COVID-19 Vaccine Uptake among African American Young Adults in the South

$692,762

Lisa B Hightow-Weidman · Florida State University · R01 · FY2024 · MD

Molecular Basis of Allergic and Immunologic Disease

$692,230

Hans C. Oettgen · Boston Children'S Hospital · T32 · FY2022 · AI

De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics

$692,102

David Baker · University Of Washington · R01 · FY2024 · AI

Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets

$691,914

John L Schroeder · Dnastar, Inc. · R44 · FY2025 · GM

Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19

$691,863

Sarah E Millar · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DC

When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States

$691,854

Becky Lynn Genberg · Johns Hopkins University · R01 · FY2023 · DA

COVID-19 Lung Microvascular and Parenchymal Sequelae (Lung-MaPS)

$691,177

Elizabeth Oelsner · Columbia University Health Sciences · R01 · FY2023 · HL

PROmotion of COVid-19 VA(X)ccination in the Emergency Department - PROCOVAXED

$691,073

Robert Rodriguez · University Of California, San Francisco · R01 · FY2022 · AI

Characterizing persistent subclinical neurobehavioral effects of COVID-19 in a diverse urban population

$690,928

Johanna Patricia Daily · Albert Einstein College Of Medicine · R01 · FY2023 · NS

Community Engagement Core

$690,902

Bibiana Marie Mancera · University Of Texas El Paso · U54 · FY2021 · MD

Implementing Community-based Approaches to Increase SARS-CoV-2 Testing among an Underserved and Vulnerable Hispanic Population

$690,902

Robert Kirken · University Of Texas El Paso · U54 · FY2021 · MD

Assessing the Impact of SARS-CoV-2 on Adipose Tissue Function and Glucose Homeostasis

$690,036

James C Lo · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · DK

An immunodominance-based Pan-Pneumovirus vaccine for protection against RSV and hMPV

$690,023

Jarrod Mousa · Florida State University · R01 · FY2024 · AI

Molecular Basis of Allergic and Immunologic Disease

Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy

An Integrated Host-Microbe Gene Classifier to Predict SARS-CoV-2 and Severe Disease in Children with Respiratory Viral Coinfections

Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy

Investigating the role of maternal-fetal crosstalk on neonatal immunity in COVID-19 infection or vaccination in pregnancy

Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery

A multidimensional Digital Approach to Address Vaccine Hesitancy and Increase COVID-19 Vaccine Uptake among African American Young Adults in the South

Molecular Basis of Allergic and Immunologic Disease

De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics

Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets

Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19

When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States

COVID-19 Lung Microvascular and Parenchymal Sequelae (Lung-MaPS)

PROmotion of COVid-19 VA(X)ccination in the Emergency Department - PROCOVAXED

Characterizing persistent subclinical neurobehavioral effects of COVID-19 in a diverse urban population

Community Engagement Core

Implementing Community-based Approaches to Increase SARS-CoV-2 Testing among an Underserved and Vulnerable Hispanic Population

Augmented Reality Platform for Telehealth Rehabilitation

Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms

Role of Complement Activation in Severe COVID-19

Modulation of Acute Lung Injury by Type I Interferon Signaling

SARS-CoV-2 Diagnostic/Prognostic Sequencing Method

New Strategy to Improve Gastrointestinal Health in SIV/HIV

Assessing the Impact of SARS-CoV-2 on Adipose Tissue Function and Glucose Homeostasis

An immunodominance-based Pan-Pneumovirus vaccine for protection against RSV and hMPV